6 American and Canadian Companies Profiting From the Ebola Virus Outbreak in West Africa

list stock 2

NewLink Genetics (NASDAQ:NLNK)

NewLink Genetics, an Ames, Iowa-based firm, reportedly has an exclusive license to an experimental Ebola vaccine developed by the Public Health Agency of Canada. CNN Money reports that the Food and Drug Administration recently “gave approval for Phase 1 clinical trials on the drug.”

A company subsidiary, BioProtection Systems Corporate, announced a $1 million contract with the U.S. Defense Threat Reduction Agency (DTRA) for research on an Ebola vaccine.

According to ibtimes.com, the company’s stock prices have jumped 34 percent in the past four weeks.

list stock 6

Sarepta Therapeutics (NASDAQ: SRPT)

Massachusetts-based biopharmaceutical company Sarepta has gained a reputation for developing treatment for rare diseases. Its stock jumped 8 percent in after-hours trading following the Centers for Disease Control and Prevention’s Tuesday announcement of an Ebola case in the U.S. The company’s CEO, Chris Garabedian, maximized the opportunity by revealing to CNBC on the same day that it has enough doses to handle about 100 patients.

The ABS Newsletter — Stories that matter, in your inbox.

Independent journalism still matters.

We hope this story was worth your time. For over 14 years, Atlanta Black Star has stayed Black-owned and independently run. We didn't get here by waiting on ad budgets that were never built to prioritize us. Our readers did that.

Corporate support for Black media has always been thin. Outlets like ours get roughly 1% of the $170 billion spent on U.S. advertising each year, and that margin is shrinking further as advertisers walk back the DEI-linked commitments they made in 2020. That's the backdrop. It's not why we're asking.

The wider picture isn't any steadier. Newspaper ad revenue has fallen more than 80% since 2005, and local newsrooms are closing at a rate of roughly two a week nationwide. When outlets go under, it's rarely the ones built to center a Black perspective from the ground up that get to stick around.

We know a request for support isn't why you came here. But without readers choosing to fund this work directly, the depth of reporting we can do at home and abroad shrinks along with everyone else's. If you're not in a position to give, that doesn't change how much we value you as a reader.

If you are able to, a recurring contribution does more for us than a single one-time gift, because it lets us plan the next investigation instead of just the next invoice. It takes about 30 seconds, no long form, no account. Thank you for continuing to support independent journalism and freedom of the press.

Latest from Atlanta Black Star

Back to top